While intellectual property played a role in building technology platforms, the real star incentive bringing vaccines and antivirals forward was public sector investment, most prominently procurement. Understanding this reality provides an opportunity for proactive planning before the next pandemic.

This is a 'Behind the Paper' view of our recent Nature Reviews Disease Primer on Multimorbidity

We propose Holistic AI in Medicine (HAIM), a unified framework to facilitate the generation and testing of AI systems that leverage multimodal inputs, and show its improvement by 6-33%. Its generalizability offers promising pathways for future multimodal predictive systems in healthcare settings.

A new biomarker appears to be an effective surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1. Broadly neutralizing antibodies (bnAbs) are defined by their ability to neutralize multiple genetically distinct viral strains.